Intranasal recombinant alfa-2b interferon treatment of naturally occurring common colds.

In a double-blind, placebo-controlled study, patients with naturally occurring common colds of less than or equal to 48 h duration were randomly assigned to receive nasal sprays of recombinant alfa-2b interferon at 10 or 20 MU/day or placebo four times per day for 5 days. The 10-MU (n = 74), 20-MU (...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Hayden, F G, Kaiser, D L, Albrecht, J K
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1988
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC172139/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2834996/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.32.2.224
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!